Assessment of quality of life in patients with trigeminal neuralgia receiving pregabalin as add-on therapy to carbamazepine

Arvind Narwat; Anjali Sindhu

doi:10.18203/2320-6012.ijrms20264177

Authors

Arvind Narwat Department of Pharmacology, Amrita School of Medicine, Amrita Vishwa Vidyapeetham, Faridabad, Haryana, India
Anjali Sindhu Department of Pathology, Shri Atal Bihari Vajpayee GMC, Chhainsa, Faridabad, Haryana, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20264177

Keywords:

Carbamazepine, Pregabalin, Trigeminal neuralgia, Pain disability index

Abstract

Background: Trigeminal neuralgia significantly affects patients’ quality of life due to recurrent, severe pain. This study aimed to compare the quality of life in patients with trigeminal neuralgia receiving pregabalin as add-on therapy to carbamazepine.

Methods: A prospective, open-label, randomized comparative study was conducted on 50 patients from November 2015 to September 2016. The patients were divided into two groups (n=25 each) and treated for 12 weeks. Group I received carbamazepine 200 mg/day, titrated up to 1000 mg/day, while Group II received pregabalin 75 mg OD plus carbamazepine 200 mg/day, with pregabalin titrated up to 300 mg/day. Quality of life was assessed using PDI at weeks 4, 8 and 12.

Results: Intragroup analysis showed a statistically significant reduction in mean PDI scores (p<0.05) from baseline at 4, 8, and 12 weeks in both groups, indicating improved quality of life. Intergroup analysis showed no significant difference at 4 weeks (p=0.15), whereas pregabalin added to carbamazepine produced significantly better quality of life at 8 and 12 weeks (p<0.05).

Conclusions: Present study suggested that pregabalin as an add on therapy was found to cause significant improvement in quality of life & reduction in pain scoring at 8^th and 12^th weeks.

References

Merskey H, Bogduk N, editors. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle: IASP Press; 1994. p. 59-60.

Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808.

Eller JL, Raslan AM, Burchiel KJ. Trigeminal neuralgia: definition and classification. Neurosurg Focus. 2005;18(5):E3.

Penman J. Trigeminal neuralgia. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Vol. 5. Amsterdam: North-Holland Publishing Company; 1968. p. 296-322.

Hall GC, Carroll D, McQuay HJ. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005. BMC Fam Pract. 2008;9:26.

Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain. 2002;95(3):259-66.

Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ. 2014 Feb 17;348:g474.

Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol. 2007;20(5):456-72.

Toda K. Operative treatment of trigeminal neuralgia: review of current techniques. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(6):788-805.

Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain. 1979;6(3):249.

Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol. 2007;20(5):456-472.

Pérez C, Navarro A, Saldaña MT, Martínez S, Rejas J. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings. Cephalalgia. 2009;29(7):781-90.

Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29(3):265-7.

Vranken JH, Dijkgraaf MGW, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008;136(1-2):150-7.

de la Calle JL, De Andres J, Pérez M, López V. Add-on treatment with pregabalin for patients with uncontrolled neuropathic pain who have been referred to pain clinics. Clin Drug Investig. 2014;34(12):833-44.